The Science of STRATTICE™ Reconstructive Tissue Matrix (RTM)

The material you choose for hernia repairs matters. Meshes have the potential to promote a negative immunologic response. This negative recognition may lead to chronic inflammation and scarring. Unlike with other biologics, proprietary tissue processing allows STRATTICE™ RTM to be positively recognized—leading to regeneration, not scar tissue.* Learn how this positive immunologic response helps make STRATTICE™ RTM the biologic mesh market leader for complex abdominal wall reconstruction.

*Correlation of these results, based on animal studies, to results in humans has not been established.

IMPORTANT SAFETY INFORMATION

INDICATIONS

STRATTICE™ Reconstructive Tissue Matrix (RTM), STRATTICE™ RTM Perforated, STRATTICE™ RTM Extra Thick, and STRATTICE™ RTM Laparoscopic are intended for use as soft tissue patches to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. Indications for use of these products include the repair of hernias and/or body wall defects which require the use of reinforcing or bridging material to obtain the desired surgical outcome. STRATTICE™ RTM Laparoscopic is indicated for such uses in open or laparoscopic procedures. These products are supplied sterile and are intended for single patient one-time use only.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS
These products should not be used in patients with a known sensitivity to porcine material and/or Polysorbate 20.

For more information, please see the Instructions for Use (IFU) for all STRATTICE™ RTM products available at www.allergan.com/StratticeIFU or call 1.800.678.1605.

To report an adverse reaction, please call Allergan at 1.800.367.5737.

STRATTICE™ and its design are trademarks of LifeCell Corporation, an AbbVie company.
All other trademarks are the property of their respective owners.
© 2021 AbbVie. All rights reserved. STM143771 02/21